Cargando…
Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in infants and young children. There are no licensed RSV vaccines available, and the few treatment options for high-risk individuals are either extremely costly or cause severe side effects and toxicit...
Autores principales: | Martinez, Elisa C., Garg, Ravendra, Shrivastava, Pratima, Gomis, Susantha, van Drunen Littel-van den Hurk, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126411/ https://www.ncbi.nlm.nih.gov/pubmed/27771388 http://dx.doi.org/10.1016/j.antiviral.2016.10.008 |
Ejemplares similares
-
Innate and Adaptive Immune Response to Pneumonia Virus of Mice in a Resistant and a Susceptible Mouse Strain
por: Watkiss, Ellen R. T., et al.
Publicado: (2013) -
Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus
por: Garg, R., et al.
Publicado: (2017) -
Effect of tunicamycin and monensin on biosynthesis, transport, and maturation of bovine herpesvirus type-1 glycoproteins
por: Van Drunen Littel-Van Den Hurk, Sylvia, et al.
Publicado: (1985) -
VP8, the Major Tegument Protein of Bovine Herpesvirus-1, Is Partially Packaged during Early Tegument Formation in a VP22-Dependent Manner
por: Sucharita, Soumya, et al.
Publicado: (2021) -
Bovine Herpesvirus-1 Glycoprotein M Mediates the Translocation to the Golgi Apparatus and Packaging of VP8
por: Sucharita, Soumya, et al.
Publicado: (2022)